Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Feb;55(2):1082-1096.
doi: 10.1007/s12035-017-0394-9. Epub 2017 Jan 14.

Evidence that NF-κB and MAPK Signaling Promotes NLRP Inflammasome Activation in Neurons Following Ischemic Stroke

David Yang-Wei Fann  1 , Yun-An Lim  2 , Yi-Lin Cheng  1 , Ker-Zhing Lok  1 , Prasad Chunduri  3 , Sang-Ha Baik  4 , Grant R Drummond  5 , S Thameem Dheen  6 , Christopher G Sobey  5 , Dong-Gyu Jo  4 , Christopher Li-Hsian Chen  2   7 , Thiruma V Arumugam  8   9
Affiliations

Evidence that NF-κB and MAPK Signaling Promotes NLRP Inflammasome Activation in Neurons Following Ischemic Stroke

David Yang-Wei Fann et al. Mol Neurobiol. 2018 Feb.

Abstract

Multi-protein complexes, termed "inflammasomes," are known to contribute to neuronal cell death and brain injury following ischemic stroke. Ischemic stroke increases the expression and activation of nucleotide-binding oligomerization domain (NOD)-like receptor (NLR) Pyrin domain containing 1 and 3 (NLRP1 and NLRP3) inflammasome proteins and both interleukin (IL)-1β and IL-18 in neurons. In this study, we provide evidence that activation of either the NF-κB and MAPK signaling pathways was partly responsible for inducing the expression and activation of NLRP1 and NLRP3 inflammasome proteins and that these effects can be attenuated using pharmacological inhibitors of these two pathways in neurons and brain tissue under in vitro and in vivo ischemic conditions, respectively. Moreover, these findings provided supporting evidence that treatment with intravenous immunoglobulin (IVIg) preparation can reduce activation of the NF-κB and MAPK signaling pathways resulting in decreased expression and activation of NLRP1 and NLRP3 inflammasomes, as well as increasing expression of anti-apoptotic proteins, Bcl-2 and Bcl-xL, in primary cortical neurons and/or cerebral tissue under in vitro and in vivo ischemic conditions. In summary, these results provide compelling evidence that both the NF-κB and MAPK signaling pathways play a pivotal role in regulating the expression and activation of NLRP1 and NLRP3 inflammasomes in primary cortical neurons and brain tissue under ischemic conditions. In addition, treatment with IVIg preparation decreased the activation of the NF-κB and MAPK signaling pathways, and thus attenuated the expression and activation of NLRP1 and NLRP3 inflammasomes in primary cortical neurons under ischemic conditions. Hence, these findings suggest that therapeutic interventions that target inflammasome activation in neurons may provide new opportunities in the future treatment of ischemic stroke.

Keywords: Inflammasome; Mitogen-activated protein kinases; NLRP; Neuronal cell death; Nuclear factor kappa B; Stroke.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Expert Rev Clin Immunol. 2011 May;7(3):301-16 - PubMed
    1. J Peripher Nerv Syst. 2013 Jun;18(2):130-40 - PubMed
    1. J Neural Transm (Vienna). 2014 May;121(5):543-7 - PubMed
    1. Cell Signal. 2004 Sep;16(9):1013-21 - PubMed
    1. Proc Natl Acad Sci U S A. 2007 Aug 28;104(35):14104-9 - PubMed

Publication types

MeSH terms

LinkOut - more resources